Take Solutions Hits 2% Upper Circuit on Wednesday; Launch of Its New AI-Driven Digital Health Platform

Take Solutions Hits 2% Upper Circuit on Wednesday; Launch of Its New AI-Driven Digital Health Platform

Take Solutions platform covers personalised nutrition and calorie management with tailored diet plans, condition-specific support for issues like diabetes, holistic wellness integration combining activity tracking and supplement recommendations, and sleep tracking and analysis

 

AI Powered Summary

On Wednesday, March 25, 2026, the Nifty 50 was trading 2.32 per cent higher at 23,450 as of 2:03 PM. Amid the broader market rally, TAKE Solutions shares are in focus after the company announced the launch of its new AI-driven digital health platform, Take.Health. As of March 25, 2026, TAKE Solutions share price is locked at the 2 per cent Upper Circuit at Rs 38.

Every portfolio needs a growth engine. DSIJ’s Flash News Investment (FNI) provides weekly stock market insights and recommendations, tailored for both short-term traders and long-term investors. Download PDF Service Note Here

TAKE Solutions Launches Take.Health 

Take.Health is built as a comprehensive platform that converts complex medical data into simple, personalised health insights. At its core, the platform offers AI-powered lab report analysis that makes medical reports easier to understand, a dynamic health dashboard that tracks parameters like vitamin levels, cholesterol and blood sugar, and predictive risk identification that enables early detection of potential health issues.

Beyond that, the platform covers personalised nutrition and calorie management with tailored diet plans, condition-specific support for issues like diabetes, holistic wellness integration combining activity tracking and supplement recommendations, and sleep tracking and analysis. The platform targets both the retail consumer segment and the enterprise or workplace segment, building recurring revenue streams across both.

India's Growing Preventive Healthcare Demand

India's healthcare market is going through a shift. People are no longer waiting to fall sick before seeing a doctor. The focus is gradually moving towards catching health issues early, tracking vitals regularly and managing lifestyle conditions before they become serious. Diseases like diabetes, cardiovascular conditions and sleep disorders are becoming more common, and with over 600 million smartphone users in the country, the ground is ready for digital health platforms to grow. It is in this environment that TAKE Solutions has launched Take.Health, a platform that takes everyday health and lifestyle data and turns it into clear, personalised health guidance for users.

The numbers backing this space are hard to ignore. India's preventive healthcare market is expected to cross USD 197 billion by 2030, while the overall healthcare sector is estimated at USD 370 billion, pointing to a large and growing opportunity for platforms built around this theme.

Management Commentary

Commenting on the launch, Parmeshvar Dhangare, Director of TAKE Solutions, said, "With healthcare rapidly transitioning toward AI-led prevention and personalised wellness, Take.Health establishes a strong strategic foothold for Take Solutions in a high-growth, future-ready segment. By leveraging a scalable, technology-driven model, the platform is expected to deepen the company's presence in digital healthcare, unlock new revenue streams through subscription and data-led services, and enhance customer lifetime value via continuous engagement. At the same time, it positions Take Solutions to capitalise on the long-term convergence of healthcare, data analytics, and technology, creating a foundation for sustained growth and innovation."

About TAKE Solutions 

TAKE Solutions Limited is a global technology company delivering domain-intensive solutions and services for the life sciences and supply chain industries. The company specialises in building scalable digital platforms and data-driven solutions, with a focus on enabling enterprises to improve efficiency, compliance and decision-making. Through its investments in AI, analytics and digital health technologies, the company serves a global clientele including innovator biopharmaceutical and medical device companies, generics manufacturers, and US federal agencies.

Add DSIJ as your preferred news source on G o o g l e

Add Now

Share your thoughts in the comments below.
Disclaimer: The article is for informational purposes only and not investment advice.